AIM: Systematic review and meta-analysis of randomized controlled trials evaluating the efficacy of emergency department-initiated tobacco control (ETC). METHODS: Literature search in 7 databases and gray literature sources. Point prevalence tobacco abstinence at 1-, 3-, 6-, and/or 12-month follow-up was abstracted from each study. The proportionate effect (relative risk) of ETC on tobacco abstinence was calculated separately for each study and follow-up time and pooled, at different follow-up times, by Mantel-Haenszel relative risks. The effects of ETC on combined point prevalence tobacco abstinence across all follow-up times were calculated using generalized linear mixed models. RESULTS: Seven studies with overall 1,986 participants were included. The strongest effect of ETC on point prevalence tobacco abstinence was found at 1 month: Relative risk (RR) = 1.47 (3 studies) (95% confidence interval [CI]: 1.06-2.06), while the effect at 3, 6, and 12 months was RR = 1.24 (6 studies) (95% CI: 0.93-1.65); 1.13 (5 studies) (95% CI: 0.86-1.49); and 1.25 (1 study) (95% CI: 0.91-1.72). The benefit on combined point prevalence tobacco abstinence was RR = 1.33 (7 studies) (95% CI: 0.96-1.83), p = .08; with RR = 1.33 (95% CI: 0.92-1.92), p = .10, for the 5 studies combining motivational interviewing and booster phone calls. CONCLUSIONS: ETC combining motivational interviewing and booster phone calls showed a trend toward increased episodically measured tobacco abstinence up to 12 months. More methodologically rigorous trials are needed to effectively evaluate the impact of ETC.
AIM: Systematic review and meta-analysis of randomized controlled trials evaluating the efficacy of emergency department-initiated tobacco control (ETC). METHODS: Literature search in 7 databases and gray literature sources. Point prevalence tobacco abstinence at 1-, 3-, 6-, and/or 12-month follow-up was abstracted from each study. The proportionate effect (relative risk) of ETC on tobacco abstinence was calculated separately for each study and follow-up time and pooled, at different follow-up times, by Mantel-Haenszel relative risks. The effects of ETC on combined point prevalence tobacco abstinence across all follow-up times were calculated using generalized linear mixed models. RESULTS: Seven studies with overall 1,986 participants were included. The strongest effect of ETC on point prevalence tobacco abstinence was found at 1 month: Relative risk (RR) = 1.47 (3 studies) (95% confidence interval [CI]: 1.06-2.06), while the effect at 3, 6, and 12 months was RR = 1.24 (6 studies) (95% CI: 0.93-1.65); 1.13 (5 studies) (95% CI: 0.86-1.49); and 1.25 (1 study) (95% CI: 0.91-1.72). The benefit on combined point prevalence tobacco abstinence was RR = 1.33 (7 studies) (95% CI: 0.96-1.83), p = .08; with RR = 1.33 (95% CI: 0.92-1.92), p = .10, for the 5 studies combining motivational interviewing and booster phone calls. CONCLUSIONS: ETC combining motivational interviewing and booster phone calls showed a trend toward increased episodically measured tobacco abstinence up to 12 months. More methodologically rigorous trials are needed to effectively evaluate the impact of ETC.
Authors: Steven L Bernstein; Gail D'Onofrio; June Rosner; Stephanie O'Malley; Robert Makuch; Susan Busch; Michael V Pantalon; Benjamin Toll Journal: Ann Emerg Med Date: 2015-04-24 Impact factor: 5.721
Authors: Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin Journal: JAMA Date: 2015-04-28 Impact factor: 56.272
Authors: E Melinda Mahabee-Gittens; Robert T Ammerman; Jane C Khoury; Lara Stone; Gabe T Meyers; John K Witry; Ashley L Merianos; Tierney F Mancuso; Kristin M W Stackpole; Berkeley L Bennett; Laura Akers; Judith S Gordon Journal: BMC Public Health Date: 2017-05-02 Impact factor: 3.295
Authors: Christina Lemhoefer; Gwen Lisa Rabe; Jürgen Wellmann; Steven L Bernstein; Ka Wai Cheung; William J McCarthy; Susanne Vahr Lauridsen; Claudia Spies; Bruno Neuner Journal: Prev Chronic Dis Date: 2017-10-05 Impact factor: 2.830
Authors: Helen Frost; Pauline Campbell; Margaret Maxwell; Ronan E O'Carroll; Stephan U Dombrowski; Brian Williams; Helen Cheyne; Emma Coles; Alex Pollock Journal: PLoS One Date: 2018-10-18 Impact factor: 3.240
Authors: William Ho Cheung Li; Ka Yan Ho; Man Ping Wang; Derek Yee Tak Cheung; Katherine Ka Wai Lam; Wei Xia; Kai Yeung Cheung; Carlos King Ho Wong; Sophia Siu Chee Chan; Tai Hing Lam Journal: JAMA Intern Med Date: 2020-02-01 Impact factor: 21.873